[Drug-induced hemolytic anemia].
D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced; D006801:Humans; D007518:Isoantibodies / Q000009:adverse effects; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000097:blood / Q000188:drug therapy; D008750:Methyldopa / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D011803:Quinine / Q000009:adverse effects; D018029:Rho(D) Immune Globulin; D013921:Thrombocytopenia / Q000139:chemically induced; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
Anémie hémolytique induite par les médicaments.